Emerging Roles of Lysyl Oxidases in the Cardiovascular System: New Concepts and Therapeutic Challenges

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2019 Oct 17

PMID 31615160

Citations 32

Authors

Jose Martinez-Gonzalez

Saray Varona

Laia Canes

Maria Galan

Ana M Briones

Victoria Cachofeiro

Cristina Rodriguez

Affiliations

Soon will be listed here.

Abstract

Lysyl oxidases (LOX and LOX-likes (LOXLs) isoenzymes) belong to a family of copper-dependent enzymes classically involved in the covalent cross-linking of collagen and elastin, a pivotal process that ensures extracellular matrix (ECM) stability and provides the tensile and elastic characteristics of connective tissues. Besides this structural role, in the last years, novel biological properties have been attributed to these enzymes, which can critically influence cardiovascular function. LOX and LOXLs control cell proliferation, migration, adhesion, differentiation, oxidative stress, and transcriptional regulation and, thereby, their dysregulation has been linked to a myriad of cardiovascular pathologies. Lysyl oxidase could modulate virtually all stages of the atherosclerotic process, from endothelial dysfunction and plaque progression to calcification and rupture of advanced and complicated plaques, and contributes to vascular stiffness in hypertension. The alteration of LOX/LOXLs expression underlies the development of other vascular pathologies characterized by a destructive remodeling of the ECM, such as aneurysm and artery dissections, and contributes to the adverse myocardial remodeling and dysfunction in hypertension, myocardial infarction, and obesity. This review examines the most recent advances in the study of LOX and LOXLs biology and their pathophysiological role in cardiovascular diseases with special emphasis on their potential as therapeutic targets.

Citing Articles

Copper ions: The invisible killer of cardiovascular disease (Review).

Wang Y, Feng L, Xu A, Ma X, Zhang M, Zhang J Mol Med Rep. 2024; 30(5).

PMID: 39301641 PMC: 11425066. DOI: 10.3892/mmr.2024.13334.

Sex differences and role of lysyl oxidase-like 2 in angiotensin II-induced hypertension in mice.

Wang H, Martinez Yus M, Brady T, Choi R, Nandakumar K, Smith L Am J Physiol Heart Circ Physiol. 2024; 327(3):H642-H659.

PMID: 39028284 PMC: 11427116. DOI: 10.1152/ajpheart.00110.2024.

Site-specific genetic and functional signatures of aortic endothelial cells at aneurysm predilection sites in healthy and AngII ApoE mice.

Bruckner A, Brandtner A, Rieck S, Matthey M, Geisen C, Fels B Angiogenesis. 2024; 27(4):719-738.

PMID: 38965173 PMC: 11564227. DOI: 10.1007/s10456-024-09933-9.

Lysyl Oxidase in Ectopic Cardiovascular Calcification: Role of Oxidative Stress.

Ballester-Servera C, Alonso J, Canes L, Vazquez-Sufuentes P, Garcia-Redondo A, Rodriguez C Antioxidants (Basel). 2024; 13(5).

PMID: 38790628 PMC: 11118817. DOI: 10.3390/antiox13050523.

The gut microbiome as a modulator of arterial function and age-related arterial dysfunction.

Longtine A, Greenberg N, Bernaldo de Quiros Y, Brunt V Am J Physiol Heart Circ Physiol. 2024; 326(4):H986-H1005.

PMID: 38363212 PMC: 11279790. DOI: 10.1152/ajpheart.00764.2023.

References

Huffman M, Curci J, Moore G, Kerns D, Starcher B, Thompson R . Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms. Surgery. 2000; 128(3):429-38. DOI: 10.1067/msy.2000.107379. View

Varona S, Orriols M, Galan M, Guadall A, Canes L, Aguilo S . Lysyl oxidase (LOX) limits VSMC proliferation and neointimal thickening through its extracellular enzymatic activity. Sci Rep. 2018; 8(1):13258. PMC: 6125287. DOI: 10.1038/s41598-018-31312-w. View

Saad F, Torres M, Wang H, Graham L . Intracellular lysyl oxidase: effect of a specific inhibitor on nuclear mass in proliferating cells. Biochem Biophys Res Commun. 2010; 396(4):944-9. DOI: 10.1016/j.bbrc.2010.05.028. View

Kagan H, Li W . Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem. 2003; 88(4):660-72. DOI: 10.1002/jcb.10413. View

Voloshenyuk T, Landesman E, Khoutorova E, Hart A, Gardner J . Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling. Cytokine. 2011; 55(1):90-7. DOI: 10.1016/j.cyto.2011.03.024. View

Barry-Hamilton V, Spangler R, Marshall D, McCauley S, Rodriguez H, Oyasu M . Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med. 2010; 16(9):1009-17. DOI: 10.1038/nm.2208. View

Kasner M, Westermann D, Lopez B, Gaub R, Escher F, Kuhl U . Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction. J Am Coll Cardiol. 2011; 57(8):977-85. DOI: 10.1016/j.jacc.2010.10.024. View

Rodriguez C, Martinez-Gonzalez J, Raposo B, Alcudia J, Guadall A, Badimon L . Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc Res. 2008; 79(1):7-13. DOI: 10.1093/cvr/cvn102. View

Lu M, Qin Q, Yao J, Sun L, Qin X . Induction of LOX by TGF-β1/Smad/AP-1 signaling aggravates rat myocardial fibrosis and heart failure. IUBMB Life. 2019; 71(11):1729-1739. DOI: 10.1002/iub.2112. View

10.

Martinez-Revelles S, Garcia-Redondo A, Avendano M, Varona S, Palao T, Orriols M . Lysyl Oxidase Induces Vascular Oxidative Stress and Contributes to Arterial Stiffness and Abnormal Elastin Structure in Hypertension: Role of p38MAPK. Antioxid Redox Signal. 2016; 27(7):379-397. PMC: 5563924. DOI: 10.1089/ars.2016.6642. View

11.

Eberson L, Sanchez P, Majeed B, Tawinwung S, Secomb T, Larson D . Effect of lysyl oxidase inhibition on angiotensin II-induced arterial hypertension, remodeling, and stiffness. PLoS One. 2015; 10(4):e0124013. PMC: 4395147. DOI: 10.1371/journal.pone.0124013. View

12.

Oleggini R, Gastaldo N, Di Donato A . Regulation of elastin promoter by lysyl oxidase and growth factors: cross control of lysyl oxidase on TGF-beta1 effects. Matrix Biol. 2007; 26(6):494-505. DOI: 10.1016/j.matbio.2007.02.003. View

13.

Gonzalez-Santamaria J, Villalba M, Busnadiego O, Lopez-Olaneta M, Sandoval P, Snabel J . Matrix cross-linking lysyl oxidases are induced in response to myocardial infarction and promote cardiac dysfunction. Cardiovasc Res. 2015; 109(1):67-78. DOI: 10.1093/cvr/cvv214. View

14.

Yamauchi M, Sricholpech M . Lysine post-translational modifications of collagen. Essays Biochem. 2012; 52:113-33. PMC: 3499978. DOI: 10.1042/bse0520113. View

15.

Akagawa H, Narita A, Yamada H, Tajima A, Krischek B, Kasuya H . Systematic screening of lysyl oxidase-like (LOXL) family genes demonstrates that LOXL2 is a susceptibility gene to intracranial aneurysms. Hum Genet. 2007; 121(3-4):377-87. DOI: 10.1007/s00439-007-0333-3. View

16.

Mitchell G . Arterial stiffness and hypertension: chicken or egg?. Hypertension. 2014; 64(2):210-4. PMC: 4185002. DOI: 10.1161/HYPERTENSIONAHA.114.03449. View

17.

Martinez-Martinez E, Rodriguez C, Galan M, Miana M, Jurado-Lopez R, Visitacion Bartolome M . The lysyl oxidase inhibitor (β-aminopropionitrile) reduces leptin profibrotic effects and ameliorates cardiovascular remodeling in diet-induced obesity in rats. J Mol Cell Cardiol. 2016; 92:96-104. DOI: 10.1016/j.yjmcc.2016.01.012. View

18.

Sibon I, Sommer P, Lamaziere J, Bonnet J . Lysyl oxidase deficiency: a new cause of human arterial dissection. Heart. 2005; 91(5):e33. PMC: 1768870. DOI: 10.1136/hrt.2004.053074. View

19.

Ovchinnikova O, Robertson A, Wagsater D, Folco E, Hyry M, Myllyharju J . T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice. Am J Pathol. 2009; 174(2):693-700. PMC: 2630576. DOI: 10.2353/ajpath.2009.080561. View

20.

Qi Y, Jiang J, Jiang X, Wang X, Ji S, Han Y . PDGF-BB and TGF-{beta}1 on cross-talk between endothelial and smooth muscle cells in vascular remodeling induced by low shear stress. Proc Natl Acad Sci U S A. 2011; 108(5):1908-13. PMC: 3033274. DOI: 10.1073/pnas.1019219108. View